… 300 U/mL (Gla-300) is a second-generation basal insulin … the first-generation basal insulin
analogue, insulin glargine 100 U/mL … trial data of insulin glargine in the Asia Pacific region are …

… In conclusion, in Asian Pacific participants with suboptimally controlled T2D on metformin
with or without a second OAD, iGlarLixi achieved significant HbA1c reductions, to near-…

… This study investigated the effect of insulin glargine (LANTUS ® ) versus NPH insulin on
metabolic control and safety in Asian patients with Type 2 diabetes, inadequately controlled on …

… Tirzepatide demonstrated superior reductions in HbA1c versus insulin glargine in an Asia-Pacific,
predominately Chinese, population with T2D and was generally well tolerated. …

… Another study that pooled and analyzed patient-level data from 15 RCTs in patients with
T2DM treated with insulin glargine indicated that increasing basal insulin doses above 0.5 IU/kg …

… - versus physician-led titration strategy for insulin glargine-based basal insulin initiation
in patients who are not controlled with two OADs in Asia and Russia. The results of the study …

… Thus, the efficacy of two insulin glargine Gla-300 and Gla-100 in large East Asian population
is worth exploration. A comprehensive evaluation of the efficacy of insulin glargine in East …

… the limitations of current basal insulin options (eg, … insulin therapy in Asia. Significant progress
has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin …

… insulin regimen at baseline are shown in Table 1. Most patients initiated insulin therapy with
insulin glargine. … the use of insulin glargine is associated with greater glycemic control than …

… that biphasic insulin aspart 30 (BIAsp 30) is more effective than insulin glargine (IGlarg)
in terms of reductions in glycohemoglobin in type 2 diabetes patients requiring insulin initiation. …